GO
Loading...

The next big drug

Monday, 13 Jan 2014 | 1:25 PM ET

CNBC's Morgan Brennan reports on the FDA's four expediting pipelines. The approval rates for the drugs in these pipelines tend to be higher than those plodding the more traditional course.